1274
A. Caporale et al.
protein (PTHrP) for distinct conformations of the PTH/PTHrP
receptor. Mol Endocrinol 22:156–166
the receptor. Also, the 50-fold reduction in activity dis-
played by analogue II relative to analogue I might reflect
the presence of a shorter side chain.
Gardella TJ, Ju¨ppner H (2001) Molecular properties of the PTH/
PTHrP receptor. Trends Endocrinol Metab 5:210–217
Gensure RC, Gardella TJ, Ju¨ppner H (2005) Parathyroid hormone and
parathyroid hormone-related peptide, and their receptors. Bio-
chem Biophys Res Commun 328:666–678
Goodman M, Listowsky I (1962) Conformational aspects of synthetic
polypeptides. VI. Hypochromic spectral studies of oligo-a-
methyl-L-glutamate peptides. J Am Chem Soc 84:3770–3771
Hoare S, Gardella T, Usdin T (2001) Evaluating the signal transduc-
tion mechanism of the parathyroid hormone 1 receptor: effect of
receptor G protein interaction on the binding mechanism and the
receptor conformation. J Biol Chem 276:7741–7753
Both the length of the positively charged side chain and
its correct orientation seem to be necessary for productive
receptor interaction. The distance of the positive charge
from the peptide backbone should be higher than four
methylene groups. Five methylenes are optimal when the
charge is linked to the main chain, while the same distance
is too short if placed in the side chain, as demonstrated by
the loss of potency on going from the Har11 to the Lys11
analogue. Specifically, the 100- and 200-fold reduction in
potency observed for analogues V and VI, containing
amino-pentyl (n = 5) and amino-hexyl groups (n = 6) in
position 11, compared to the analogue containing homo-
arginine, suggests that the search for potent PTH analogues
should consider the modification of the L-Har side chain, to
keep the positive charge in the correct orientation.
Hruby VJ (2002) Designing peptide receptor agonists and antagonists.
Nat Rev 1:847–858
Jin L, Briggs SL, Chandrasekhar S, Chirgadze NY, Clawson DK,
Schevitz RW, Smiley DL, Tashjian AH, Zhang F (2000) Crystal
˚
structure of human parathyroid hormone 1 34 at 0.9 A resolu-
tion. J Biol Chem 275:27238–27244
Ju¨ppner H, Abou-Samra A-B, Freeman M, Kong X-F, Schipani E,
Richards J, Kolakowski LF Jr, Hock J, Potts JT Jr, Kronenberg
HM, Segre GV (1991) A G protein-linked receptor for parathy-
roid hormone and parathyroid hormone-related peptide. Science
254:1024–1026
Acknowledgments The authors thank: MIUR, Ministry of Educa-
tion and University of Italy, and CNR, the National Council of
Research of Italy for funding and Dr Barbara Biondi for friendly help
in synthesis and mass spectroscopy analysis.
Kolakowski LF (1994) GCRDb: a G-protein-coupled receptor data-
base. Recept Channels 2:1–7
Konig W, Geiger R (1970) A new method for the synthesis of
peptides: activation of the carboxyl group with dicyclohexylcar-
bodiimide and 1-hydroxybenzotriazole. Chem Berl 103:788
Kronenberg H, Abou-Samra A, Bringhurst F, Gardella T, Ju¨ppner H,
Segre G (1997) Genetics of endocrine and metabolic disorders.
In: Thakker R (ed). Chapman & Hall, London, pp 389–420
Kruijtzer JAW, Hofmeyer LJF, Heerma W, Versluis C, Liskamp RMJ
(1998) Solid-phase syntheses of peptoids using Fmoc-protected
N-substituted glycines: the synthesis of (retro)peptoids of leu-
enkephalin and substance P. Chem Eur J 4:1570–1580
Lim S-K, Lee E-J, Kim H-Y, Lee W (2004) The 10th and 11th
residues of short length N-terminal PTH(/1–12) analogue are
important for its optimum potency. J Pept Res 64:25–32
Monticelli L, Mammi S, Mierke DF (2002) Molecular characteriza-
tion of a ligand-tethered parathyroid hormone receptor. Biophys
Chem 95(2):165–172
Pellegrini M, Royo M, Rosenblatt M, Chorev M, Mierke DF (1998)
Addressing the tertiary structure of human parathyroid hormone-
(1–34). J Biol Chem 273:10420–10427
¨
Rolz C, Pellegrini M, Mierke DF (1999) Molecular characterization
of the receptor–ligand complex for parathyroid hormone.
Biochemistry 38:6397–6405
Shimizu M, Potts J T Jr, Gardella TJ (2000) Minimization of
parathyroid hormone. Novel amino-terminal parathyroid hor-
mone fragments with enhanced potency in activating the type-1
parathyroid hormone receptor. J Biol Chem 275:21836–21843
Shimizu M, Carter PH, Khatri A, Potts J T Jr, Gardella TJ (2001a)
Enhanced activity in parathyroid hormone-(1–14) and -(1–11):
novel peptides for probing ligand–receptor interactions. Endo-
crinology 142:3068–3074
Shimizu N, Guo J, Gardella TJ (2001b) Parathyroid hormone (1–14)
and (1–11) analogs conformationally constrained by alpha
aminoisobutyric acid mediate full agonist responses via the
juxtamembrane region of the PTH 1 receptor. J Biol Chem
276:49003–49012
References
Adessi C, Soto C (2002) Converting a peptide into a drug: strategies
to improve stability and bioavailability. Curr Med Chem 9:963–
978
Barazza A, Wittelsberger A, Fiori N, Schievano E, Mammi S, Toniolo
C, Alexander JM, Rosenblatt M, Peggion E, Chorev M (2005)
Bioactive N-terminal undecapeptides derived from parathyroid
hormone: the role of alpha-helicity. J Pept Res 65(1):23–35
Buck M (1998) Trifluoroethanol and colleagues: cosolvents come of
age. Q Rev Biophys 31:297–355
Caporale A, Fiori N, Schievano E, Mammi S, Wittelsberger A,
Chorev M, Peggion E. (2006) Structure–function relationship of
analogues of PTH(1–11) fragments containing a combination of
Aib and (a-Me)Val. In: Proceedings of 29th European peptides
symposim, Gdansk, Poland, pp 424–425
Caporale A, Biondi B, Schievano E, Wittelsberger A, Mammi S,
Peggion E (2009) Structure–function relationship studies of
PTH(1–11) analogues containing D-amino acids. Eur J Pharm
611:1–7
Carpino LA (1993) 1-Hydroxy-7-azabenzotriazole. An efficient
peptide coupling additive. J Am Chem Soc 115:4397–4398
Carpino LA, El-Faham A (1994) Effect of tertiary bases on O-
benzotriazolyluronium salt-induced peptide segment coupling.
J Org Chem 59:695–698
Carpino LA, El-Faham A, Minor CA, Albericio F (1994) Advanta-
geous applications of azabenzotriazole (triazolopyridine)-based
coupling reagents to solid-phase peptide synthesis. J Soc Chem
Comm 201–203
Castro M, Nikolaev VO, Palm D, Lohse MJ, Vilardaga JP (2005)
Turn-on switch in parathyroid hormone receptor by a two-step
parathyroid hormone binding mechanism. Proc Natl Acad Sci
USA 102:16084–16089
Dean T, Vilardaga JP, Potts JT Jr, Gardella TJ (2008) Altered
selectivity of parathyroid hormone (PTH) and PTH-related
Shimizu M, Petroni BD, Khatri A, Gardella TJ (2003) Functional
evidence for an intramolecular side chain interaction between
residues 6 and 10 of receptor-bound parathyroid hormone
analogues. Biochemistry 42:2282–2290
123